ANTI-CD71 ACTIVATABLE ANTIBODY DRUG CONJUGATES AND METHODS OF USE THEREOF

The invention relates generally to conjugated activatable antibodies that bind CD71 in their active form and methods of making and using these anti-CD71 conjugated activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.

Saved in:
Bibliographic Details
Main Authors Singh, Shweta, Serwer, Laura Patterson, Henriques, Tracy, Morgan-Lappe, Susan E, Bose, Sahana, Richardson, Jennifer Hope, Badagnani, Ilaria, Terrett, Jonathan Alexander, Ralston, Sherry L, Leanna, Marvin Robert
Format Patent
LanguageCroatian
English
Published 07.01.2022
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates generally to conjugated activatable antibodies that bind CD71 in their active form and methods of making and using these anti-CD71 conjugated activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
Bibliography:Application Number: HR2021P000436T